ICD   PCS   Disclaimer
ICD-10-CM-2022 Diagnosis Codes Overview
ICD-10-CM-2022 > P00-P96 > P00-P04 > P04
P00-P04
Newborn affected by maternal factors and by complications of pregnancy, labor, and delivery
Info:
These codes are for use when the listed maternal conditions are specified as the cause of confirmed morbidity or potential morbidity which have their origin in the perinatal period (before birth through the first 28 days after birth).
P04

Newborn affected by noxious substances transmitted via placenta or breast milk

Incl.:
nonteratogenic effects of substances transmitted via placenta
Code first
any current condition in newborn, if applicable
Excl2.:
congenital malformations (Q00-Q99)
encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)
neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)
newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)
P04.0
Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery
Info:
Newborn affected by reactions and intoxications from maternal opiates and tranquilizers administered for procedures during pregnancy or labor and delivery
Excl2.:
newborn affected by other maternal medication (P04.1-)
P04.1

Newborn affected by other maternal medication

Code first
withdrawal symptoms from maternal use of drugs of addiction, if applicable (P96.1)
Excl1.:
dysmorphism due to warfarin (Q86.2)
fetal hydantoin syndrome (Q86.1)
Excl2.:
maternal anesthesia and analgesia in pregnancy, labor and delivery (P04.0)
maternal use of drugs of addiction (P04.4-)
P04.11
Newborn affected by maternal antineoplastic chemotherapy
P04.12
Newborn affected by maternal cytotoxic drugs
P04.13
Newborn affected by maternal use of anticonvulsants
P04.14
Newborn affected by maternal use of opiates
P04.15
Newborn affected by maternal use of antidepressants
P04.16
Newborn affected by maternal use of amphetamines
P04.17
Newborn affected by maternal use of sedative-hypnotics
P04.1A
Newborn affected by maternal use of anxiolytics
P04.18
Newborn affected by other maternal medication
P04.19
Newborn affected by maternal use of unspecified medication
P04.2
Newborn affected by maternal use of tobacco
Info:
Newborn affected by exposure in utero to tobacco smoke
Excl2.:
newborn exposure to environmental tobacco smoke (P96.81)
P04.3
Newborn affected by maternal use of alcohol
Excl1.:
fetal alcohol syndrome (Q86.0)
P04.4

Newborn affected by maternal use of drugs of addiction

P04.40
Newborn affected by maternal use of unspecified drugs of addiction
P04.41
Newborn affected by maternal use of cocaine
P04.42
Newborn affected by maternal use of hallucinogens
Excl2.:
newborn affected by other maternal medication (P04.1-)
P04.49
Newborn affected by maternal use of other drugs of addiction
Excl2.:
newborn affected by maternal anesthesia and analgesia (P04.0)
withdrawal symptoms from maternal use of drugs of addiction (P96.1)
P04.5
Newborn affected by maternal use of nutritional chemical substances
P04.6
Newborn affected by maternal exposure to environmental chemical substances
P04.8

Newborn affected by other maternal noxious substances

P04.81
Newborn affected by maternal use of cannabis
P04.89
Newborn affected by other maternal noxious substances
P04.9
Newborn affected by maternal noxious substance, unspecified

 

ICD-10-CM-2022 Code Search Engine and PCS-2022 Code Search Engine